ISG15 functions as an interferon-mediated antiviral effector early in the murine norovirus life cycle

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9277-9286

  Rodriguez, Marisela R ^a   Monte, Kristen ^a   Thackray, Larissa B ^a   Lenschow, Deborah J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERFERON STIMULATED GENE 15; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; EFFECTOR CELL; EMBRYO; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; INFECTION PREVENTION; MACROPHAGE; MOUSE; MURINE NOROVIRUS 1; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; PROTEIN FUNCTION; VIROGENESIS; VIRUS ENTRY; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS UNCOATING;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CYTOKINES; DENDRITIC CELLS; FIBROBLASTS; GENOME, VIRAL; INTERFERON TYPE I; LIFE CYCLE STAGES; MACROPHAGES; MICE; MICE, INBRED C57BL; NOROVIRUS; TRANSCRIPTION, GENETIC; UBIQUITINS; VIRUS REPLICATION;

EID: 84904878503     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01422-14     Document Type: Article

References (63)

1. Wobus CE, Thackray LB, Virgin HW, IV. 2006. Murine norovirus: a model system to study norovirus biology and pathogenesis. J. Virol. 80: 5104-5112. http://dx.doi.org/10.1128/JVI.02346-05.
2. Estes MK, Prasad BV, Atmar RL. 2006. Noroviruses everywhere: has something changed? Curr. Opin. Infect. Dis. 19:467-474. http://dx.doi.org/10.1097/01.qco.0000244053.69253.3d.
3. Matthews JE, Dickey BW, Miller RD, Felzer JR, Dawson BP, Lee AS, Rocks JJ, Kiel J, Montes JS, Moe CL, Eisenberg JN, Leon JS. 2012. The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup. Epidemiol. Infect. 140:1161-1172. http://dx.doi.org/10.1017/S0950268812000234.
4. Glass RI, Parashar UD, Estes MK. 2009. Norovirus gastroenteritis. N. Engl. J. Med. 361:1776-1785. http://dx.doi.org/10.1056/NEJMra0804575.
5. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW, IV. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299: 1575-1578. http://dx.doi.org/10.1126/science.1077905.
6. Mumphrey SM, Changotra H, Moore TN, Heimann-Nichols ER, Wobus CE, Reilly MJ, Moghadamfalahi M, Shukla D, Karst SM. 2007. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1-dependent interferon responses. J. Virol. 81:3251-3263. http://dx.doi.org/10.1128/JVI.02096-06.
7. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, Belliot G, Krug A, Mackenzie JM, Green KY, Virgin HW. 2004. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2:e432. http://dx.doi.org/10.1371/journal.pbio.0020432.
8. McFadden N, Bailey D, Carrara G, Benson A, Chaudhry Y, Shortland A, Heeney J, Yarovinsky F, Simmonds P, Macdonald A, Goodfellow I. 2011. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. PLoS Pathog. 7:e1002413. http://dx.doi.org/10.1371/journal.ppat.1002413.
9. Hyde JL, Mackenzie JM. 2010. Subcellular localization of the MNV-1 ORF1 proteins and their potential roles in the formation of the MNV-1 replication complex. Virology 406:138-148. http://dx.doi.org/10.1016/j.virol.2010.06.047.
10. Strong DW, Thackray LB, Smith TJ, Virgin HW. 2012. Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo. J. Virol. 86:2950-2958. http://dx.doi.org/10.1128/JVI.07038-11.
11. Maloney NS, Thackray LB, Goel G, Hwang S, Duan E, Vachharajani P, Xavier R, Virgin HW. 12 September 2012. Essential cell autonomous role for interferon regulatory factor 1 in interferon-gamma-mediated inhibition of norovirus replication in macrophages. J. Virol. http://dx.doi.org/10.1128/JVI.01564-12.
12. Thackray LB, Duan E, Lazear HM, Kambal A, Schreiber RD, Diamond MS, Virgin HW. 3 October 2012. Critical role for IRF-3 and IRF-7 in type I interferon-mediated control of murine norovirus replication. J. Virol. http://dx.doi.org/10.1128/JVI.01824-12.
13. Hwang S, Maloney NS, Bruinsma MW, Goel G, Duan E, Zhang L, Shrestha B, Diamond MS, Dani A, Sosnovtsev SV, Green KY, Lopez-Otin C, Xavier RJ, Thackray LB, Virgin HW. 2012. Nondegradative role of Atg5-Atg12/ Atg16L1 autophagy protein complex in antiviral activity of interferon gamma. Cell Host Microbe 11:397-409. http://dx.doi.org/10.1016/j.chom.2012.03.002.
14. Bailey D, Thackray LB, Goodfellow IG. 2008. A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo. J. Virol. 82:7725-7728. http://dx.doi.org/10.1128/JVI.00237-08.
15. Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, Clepper L, Thackray L, Brassil MM, Virgin HW, Nikolich-Zugich J, Moses AV, Gale M, Jr, Fruh K, Diamond MS. 2013. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 9:e1003118. http://dx.doi.org/10.1371/journal.ppat.1003118.
16. Perry JW, Wobus CE. 2010. Endocytosis of murine norovirus 1 into murine macrophages is dependent on dynamin II and cholesterol. J. Virol. 84:6163-6176. http://dx.doi.org/10.1128/JVI.00331-10.
17. Gerondopoulos A, Jackson T, Monaghan P, Doyle N, Roberts LO. 2010. Murine norovirus-1 cell entry is mediated through a non-clathrin-, noncaveolae-, dynamin-and cholesterol-dependent pathway. J. Gen. Virol. 91:1428-1438. http://dx.doi.org/10.1099/vir.0.016717-0.
18. Changotra H, Jia Y, Moore TN, Liu G, Kahan SM, Sosnovtsev SV, Karst SM. 2009. Type I and type II interferons inhibit the translation of murine norovirus proteins. J. Virol. 83:5683-5692. http://dx.doi.org/10.1128/JVI.00231-09.
19. McCartney SA, Thackray LB, Gitlin L, Gilfillan S, Virgin HW, IV, Colonna M. 2008. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4:e1000108. http://dx.doi.org/10.1371/journal.ppat.1000108.
20. Lai C, Struckhoff JJ, Schneider J, Martinez-Sobrido L, Wolff T, Garcia-Sastre A, Zhang DE, Lenschow DJ. 12 November 2008. Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection. J. Virol. http://dx.doi.org/10.1128/JVI.00105-08.
21. Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O'Guin AK, Schmidt RE, Levine B, Virgin HW, IV. 2005. Identification of interferonstimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 79:13974-13983. http://dx.doi.org/10.1128/JVI.79.22.13974-13983.2005.
22. Lenschow DJ, Lai C, Frias-Staheli N, Giannakopoulos NV, Lutz A, Wolff T, Osiak A, Levine B, Schmidt RE, Garcia-Sastre A, Leib DA, Pekosz A, Knobeloch KP, Horak I, Virgin HW, IV. 2007. IFNstimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc. Natl. Acad. Sci. U. S. A. 104:1371-1376. http://dx.doi.org/10.1073/pnas.0607038104.
23. Rodriguez MR, Campbell JA, Lenschow DJ. 2011. Chapter 4. Antiviral function of interferons. In Mossman K (ed), Viruses and interferon: current research. Horizon Scientific Press, Poole, United Kingdom.
24. Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ. 2011. ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog. 7:e1002322. http://dx.doi.org/10.1371/journal.ppat.1002322.
25. Yuan W, Krug RM. 2001. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J. 20:362-371. http://dx.doi.org/10.1093/emboj/20.3.362.
26. Zhao C, Beaudenon SL, Kelley ML, Waddell MB, Yuan W, Schulman BA, Huibregtse JM, Krug RM. 2004. The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein. Proc. Natl. Acad. Sci. U. S. A. 101:7578-7582. http://dx.doi.org/10.1073/pnas.0402528101.
27. Dastur A, Beaudenon S, Kelley M, Krug RM, Huibregtse JM. 2006. Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. J. Biol. Chem. 281:4334-4338. http://dx.doi.org/10.1074/jbc.M512830200.
28. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM. 2005. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102:10200-10205. http://dx.doi.org/10.1073/pnas.0504754102.
29. Zou W, Zhang DE. 2006. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase. J. Biol. Chem. 281:3989-3994. http://dx.doi.org/10.1074/jbc.M510787200.
30. Oudshoorn D, van Boheemen S, Sanchez-Aparicio MT, Rajsbaum R, Garcia-Sastre A, Versteeg GA. 2012. HERC6 is the main E3 ligase for global ISG15 conjugation in mouse cells. PLoS One 7:e29870. http://dx.doi.org/10.1371/journal.pone.0029870.
31. Malakhov MP, Malakhova OA, Kim KI, Ritchie KJ, Zhang DE. 2002. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277:9976-9981. http://dx.doi.org/10.1074/jbc.M109078200.
32. Knight E, Jr, Cordova B. 1991. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146:2280-2284.
33. D'Cunha J, Knight E, Jr, Haas AL, Truitt RL, Borden EC. 1996. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. U. S. A. 93:211-215. http://dx.doi.org/10.1073/pnas.93.1.211.
34. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E, Jr, Borden EC. 1996. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J. Immunol. 157:4100-4108.
35. Hsiang TY, Zhao C, Krug RM. 8 April 2009. Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J. Virol. http://dx.doi.org/10.1128/JVI.01667-08.
36. Okumura A, Pitha PM, Harty RN. 2008. ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc. Natl. Acad. Sci. U. S. A. 105:3974-3979. http://dx.doi.org/10.1073/pnas.0710629105.
37. Okumura A, Lu G, Pitha-Rowe I, Pitha PM. 2006. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 103:1440-1445. http://dx.doi.org/10.1073/pnas.0510518103.
38. Malakhova OA, Zhang DE. 2008. ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J. Biol. Chem. 283: 8783-8787. http://dx.doi.org/10.1074/jbc.C800030200.
39. Sanyal S, Ashour J, Maruyama T, Altenburg AF, Cragnolini JJ, Bilate A, Avalos AM, Kundrat L, Garcia-Sastre A, Ploegh HL. 2013. Type I interferon imposes a TSG101/ISG15 checkpoint at the Golgi for glycoprotein trafficking during influenza virus infection. Cell Host Microbe 14: 510-521. http://dx.doi.org/10.1016/j.chom.2013.10.011.
40. Cadwell K, Patel KK, Maloney NS, Liu TC, Ng AC, Storer CE, Head RD, Xavier R, Stappenbeck TS, Virgin HW. 2010. Virus-plussusceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 141:1135-1145. http://dx.doi.org/10.1016/j.cell.2010.05.009.
41. Kim KI, Yan M, Malakhova O, Luo JK, Shen MF, Zou W, de la Torre JC, Zhang DE. 2006. UbE1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol. Cell. Biol. 26:472-479. http://dx.doi.org/10.1128/MCB.26.2.472-479.2006.
42. Osiak A, Utermohlen O, Niendorf S, Horak I, Knobeloch KP. 2005. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell. Biol. 25:6338-6345. http://dx.doi.org/10.1128/MCB.25.15.6338-6345.2005.
43. Takeshita S, Kaji K, Kudo A. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15:1477-1488. http://dx.doi.org/10.1359/jbmr.2000.15.8.1477.
44. Barchet W, Krug A, Cella M, Newby C, Fischer JA, Dzionek A, Pekosz A, Colonna M. 2005. Dendritic cells respond to influenza virus through TLR7-and PKR-independent pathways. Eur. J. Immunol. 35:236-242. http://dx.doi.org/10.1002/eji.200425583.
45. Chachu KA, Strong DW, LoBue AD, Wobus CE, Baric RS, Virgin HW, IV. 2008. Antibody is critical for the clearance of murine norovirus infection. J. Virol. 82:6610-6617. http://dx.doi.org/10.1128/JVI.00141-08.
46. Sosnovtsev SV, Belliot G, Chang KO, Prikhodko VG, Thackray LB, Wobus CE, Karst SM, Virgin HW, Green KY. 2006. Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells. J. Virol. 80:7816-7831. http://dx.doi.org/10.1128/JVI.00532-06.
47. Rohayem J, Bergmann M, Gebhardt J, Gould E, Tucker P, Mattevi A, Unge T, Hilgenfeld R, Neyts J. 2010. Antiviral strategies to control calicivirus infections. Antiviral Res. 87:162-178. http://dx.doi.org/10.1016/j.antiviral.2010.05.002.
48. Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. 2005. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem. Biophys. Res. Commun. 336:496-506. http://dx.doi.org/10.1016/j.bbrc.2005.08.132.
49. Cornely R, Rentero C, Enrich C, Grewal T, Gaus K. 2011. Annexin A6 is an organizer of membrane microdomains to regulate receptor localization and signalling. IUBMB Life 63:1009-1017. http://dx.doi.org/10.1002/iub.540.
50. de Diego I, Schwartz F, Siegfried H, Dauterstedt P, Heeren J, Beisiegel U, Enrich C, Grewal T. 2002. Cholesterol modulates the membrane binding and intracellular distribution of annexin 6. J. Biol. Chem. 277: 32187-32194. http://dx.doi.org/10.1074/jbc.M205499200.
51. Grewal T, Heeren J, Mewawala D, Schnitgerhans T, Wendt D, Salomon G, Enrich C, Beisiegel U, Jackle S. 2000. Annexin VI stimulates endocytosis and is involved in the trafficking of low density lipoprotein to the prelysosomal compartment. J. Biol. Chem. 275:33806-33813. http://dx.doi.org/10.1074/jbc.M002662200.
52. Enrich C, Rentero C, de Muga SV, Reverter M, Mulay V, Wood P, Koese M, Grewal T. 2011. Annexin A6-linking Ca(2+) signaling with cholesterol transport. Biochim. Biophys. Acta 1813:935-947.
53. Domon MM, Matar G, Strzelecka-Kiliszek A, Bandorowicz-Pikula J, Pikula S, Besson F. 2010. Interaction of annexin A6 with cholesterol rich membranes is pH-dependent and mediated by the sterol OH. J. Colloid Interface Sci. 346:436-441. http://dx.doi.org/10.1016/j.jcis.2010.03.015.
54. Sztolsztener ME, Strzelecka-Kiliszek A, Pikula S, Tylki-Szymanska A, Bandorowicz-Pikula J. 2010. Cholesterol as a factor regulating intracellular localization of annexin A6 in Niemann-Pick type C human skin fibroblasts. Arch. Biochem. Biophys. 493:221-233.
55. Hayes MJ, Rescher U, Gerke V, Moss SE. 2004. Annexin-actin interactions. Traffic 5:571-576. http://dx.doi.org/10.1111/j.1600-0854.2004.00210.x.
56. Rescher U, Ruhe D, Ludwig C, Zobiack N, Gerke V. 2004. Annexin 2 is a phosphatidylinositol (4,5)-bisphosphate binding protein recruited to actin assembly sites at cellular membranes. J. Cell Sci. 117:3473-3480. http://dx.doi.org/10.1242/jcs.01208.
57. Hosoya H, Kobayashi R, Tsukita S, Matsumura F. 1992. Ca(2+)-regulated actin and phospholipid binding protein (68 kDa-protein) from bovine liver: identification as a homologue for annexin VI and intracellular localization. Cell Motil. Cytoskeleton 22:200-210. http://dx.doi.org/10.1002/cm.970220307.
58. Lin HC, Sudhof TC, Anderson RG. 1992. Annexin VI is required for budding of clathrin-coated pits. Cell 70:283-291. http://dx.doi.org/10.1016/0092-8674(92)90102-I.
59. Newman R, Tucker A, Ferguson C, Tsernoglou D, Leonard K, Crumpton MJ. 1989. Crystallization of p68 on lipid monolayers and as threedimensional single crystals. J. Mol. Biol. 206:213-219. http://dx.doi.org/10.1016/0022-2836(89)90534-2.
60. Heyraud S, Jaquinod M, Durmort C, Dambroise E, Concord E, Schaal JP, Huber P, Gulino-Debrac D. 2008. Contribution of annexin 2 to the architecture of mature endothelial adherens junctions. Mol. Cell. Biol. 28:1657-1668. http://dx.doi.org/10.1128/MCB.00695-07.
61. Edwards HC, Crumpton MJ. 1991. Ca(2+)-dependent phospholipid and arachidonic acid binding by the placental annexins VI and IV. Eur. J. Biochem. 198:121-129. http://dx.doi.org/10.1111/j.1432-1033.1991.tb15994.x.
62. Recht M, Borden EC, Knight E, Jr. 1991. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147:2617-2623.
63. Owhashi M, Taoka Y, Ishii K, Nakazawa S, Uemura H, Kambara H. 2003. Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor. Biochem. Biophys. Res. Commun. 309:533-539. http://dx.doi.org/10.1016/j.bbrc.2003.08.038.